
From Lab to C-Suite, Then Turning Around a Startup, ft. George Scangos (Biogen)
Wisdom From The Top with Guy Raz
00:00
Leadership and Crisis in Pharma
This chapter explores a company's remarkable turnaround under new leadership, followed by a startling decline in stock price linked to safety concerns over its MS medication, Tecfidera. It delves into the critical importance of transparency and responsibility in pharmaceutical crises, illustrated through Biogen's response to issues surrounding the drug Tysabri.
Transcript
Play full episode